BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Alpha Methyltyrosine

An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)

300+ PubMed studies analyzed · Evidence Score: 44.9

Research Domains

Alpha Methyltyrosine has been studied across 22 research domains including 🧠 Focus & Attention, 🌤️ Mood & Depression, 🔬 Oncology, ⏳ Longevity & Aging, 🫘 Kidney. The primary research focus is 🧠 Focus & Attention with 53% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Alpha Methyltyrosine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

cycloserine
2 shared targets
Folic
2 shared targets
Ouabain
2 shared targets
Oxytetracycline
2 shared targets
tyrphostin
2 shared targets
Fluspirilene
2 shared targets
Clotrimazole
2 shared targets
bufo
2 shared targets
mylabris
2 shared targets
curculigo
2 shared targets
Loading evidence profile...

This evidence profile for Alpha Methyltyrosine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.